Skip to main content

Risk factors associated with surgical site infections following joint replacement surgery: a narrative review

Abstract

Background

Surgical site infection following joint replacement surgery is still a significant complication, resulting in repeated surgery, prolonged antibiotic therapy, extended postoperative hospital stay, periprosthetic joint infection, and increased morbidity and mortality. This review discusses the risk factors associated with surgical site infection.

Related risk factors

The patient-related factors include sex, age, body mass index (BMI), obesity, nutritional status, comorbidities, primary diagnosis, living habits, and scores of the American Society of Anesthesiologists physical status classification system, etc. Surgery-related factors involve preoperative skin preparation, prolonged duration of surgery, one-stage bilateral joint replacement surgery, blood loss, glove changes, anti-microbial prophylaxis, topical anti-bacterial preparations, wound management, postoperative hematoma, etc. Those risk factors are detailed in the review.

Conclusion

Preventive measures must be taken from multiple perspectives to reduce the incidence of surgical site infection after joint replacement surgery.

Introduction

Surgical site infection (SSI) represents one of the major complications of joint replacement surgery (JRS). It possibly extends postoperative hospital stay, prolongs the antibiotic therapies, and leads to periprosthetic joint infection (PJI). PJI is a devastating and challenging complication that increases morbidity and mortality rates [1]. Although the incidences of PJI range from 1% to 2.4% [2, 3], it may cause significant psychological stress to patients and pose a heavy economic burden to a country [4]. Many orthopedic surgeons are focusing on the potential ways to minimize the occurrence of SSI. Multiple researchers have pointed out that the SSI rate is multi-factorial, including patient susceptibility and environmental and social aspects. In this review, we elaborate on the risk factors associated with post-JRS SSI, with a hope to arouse orthopedists’ attention to SSI and PJI.

Patient factors

Sex and age

Older patients are particularly vulnerable to post-total hip arthroplasty (THA) infection due to low immune resistance and poor nutritional status [5,6,7,8]. However, Muilwijk et al. [9] revealed no association between age and SSI after primary THA. Baier et al.[10] did not find statistically significant differences between the age groups in terms of SSI after total knee arthroplasty (TKA). Many studies demonstrated that male patients had a higher SSI and PJI rate than their female counterparts and the difference was more significant in TKA [11,12,13,14,15].

Body Mass Index (BMI) and Obesity

Obese patients have relatively higher SSI rates than non-obese patients [6, 14, 16,17,18]. A BMI ≥ 32 was found to be associated with high risks of SSI [19]. Falagas et al. [20] found that adipose tissue played an active role in inflammation and immunity through multiple inflammatory cytokines and immune mediators, making obese patients more susceptible to infection. Therefore, preoperative weight control and dieting are critical to reducing the risk of SSI.

Nutritional status

Malnutrition is one of the common risk factors. Pruzansky et al. [21] determined albumin or total lymphocyte levels to assess the nutritional status and found that malnutrition was associated with a high incidence of SSI. Rasouli et al. [22] revealed that low preoperative hemoglobin levels increased the risk of SSI.

Comorbidities

Diabetes mellitus

Diabetes Mellitus is associated with wound complications [6, 23, 24]. Pruzansky et al. [21] reported that 20% of patients with SSI had diabetes. In diabetic patients, inadequate perioperative glycemic control is associated with an increased risk of postoperative SSI. HbA1c is a biomarker for diagnosing and treating diabetes, but a cutoff of 7% alone cannot be used for risk stratification [25]. Fructosamine, glycosylated albumin, and 1.5-anhydroglucytol may be more sensitive measures because HbA1c often produces false findings in patients with both chronic kidney disease and anemia [26].

Rheumatoid arthritis

Patients with rheumatoid arthritis are prone to SSI because they often receive hormones and immunosuppressants. Many studies have confirmed that rheumatoid arthritis is associated with a high incidence of SSI [16, 27, 28].

Asymptomatic bacteriuria

Asymptomatic bacteriuria and urinary tract infection are the two major urinary tract diseases leading to an increased incidence of SSI. In a multicenter cohort study that enrolled 2,497 JRS patients, Sousa et al. [29] reported that the PJI rate was significantly higher in the asymptomatic bacteriuria group than in the non-asymptomatic bacteriuria group (odds ratio, 3.23; Cl, 1.67–6.27; P = 0.001). In a systematic review and meta-analysis, Gómez-Ochoa et al. [30] exhibited that the SSI incidence of the asymptomatic bacteriuria group was higher (2.3% vs. 1.1%). Parvizi et al. [31] found that urinary tract infection was an independent predictor for PJI. The latest research findings showed preoperative (not postoperative) urinary tract infection increased the risk of superficial wound infection and deep PJI [32].

Peripheral vascular disease

Marusic et al. [33] reported that early peripheral vascular diseases led to 6.4 times and 3.5 times the risks of SSI after THA and TKA, respectively, due to tissue hypoxia and delayed wound healing. Park et al. [34] demonstrated that the post-TKA arterial complications probably led to delayed wound healing, skin necrosis, deep infection and other complications.

Chronic skin disease

A 4-year retrospective cohort study that included 2439 patients, suggested that chronic skin disease (e.gg., atopic dermatitis, psoriasis) was involved in an increased risk of SSI [9]. Kawata et al. [10] also revealed that atopic dermatitis was an independent demographic risk factor for SSI after anterior cruciate ligament reconstruction.

Revision JRS

Revision JRS carries a higher SSI rate due to the long operative time and the previous scars that affect wound healing. De Jong et al. [35] suggested the deep infection rate of hemiarthroplasty was increased following femur neck fractures (OR 15.2, P < 0.001). Everhart et al. [28] reported that the infection rate of revision shoulder arthroplasty was 9.1%. Pugely et al. [36] demonstrated that SSI rates of revision JRS was high, especially in hip revision arthroplasty.

Other factors

Femoral head osteonecrosis, osteoarthritis, post-traumatic arthritis, hip dysplasia may not be associated with SSI [14].

Living habits

Smoking

Many studies showed that smoking increased the incidence of postoperative SSI. In a systematic review of primary JRS patients, Bedard et al. [37] showed smokers had significantly higher risks of wound complications and PJI than non-smokers in both current and former smoking settings. Liang et al. [19] indicated that smoking (OR, 4.2; 95% CI, 2.1–6.4) was an independent risk factor associated with SSI.

Alcohol abuse

Few articles reported on the relationship between alcohol abuse and SSI. Wu et al. [6] and Poultsides et al. [12] demonstrated that alcohol abuse carried a 1.57- to 2.95-fold higher risk of PJI. Excessive alcohol consumption (45 g/day for men and 30 g/day for women) is commonly found in patients with an infected THA due to impaired liver function and a weakened immune system [7].

American Society of Anesthesiologists (ASA) Score

Anesthesiologists often use the ASA score to assess patients’ overall preoperative health condition. Paryavi et al. [38] showed that ASA class 3 or higher predicted infection with an odds ratio of 2.87. Namba et al. [14] found ASA classes 1 and 2 were more closely associated with lower SSI rates than the higher ASA classes (0.34% vs. 0.80%). Yang et al. [39] demonstrated that the adjusted odds ratios in univariate and multivariate analyses for ASA score were 1.77 and 3.36, respectively. They found that an ASA class ≥ 3 was an independent risk factor for SSI.

Surgery-related factors

Preoperative skin preparation

The optimal disinfectant used for preoperative skin preparation remains controversial. Zywiel et al. [40] found chlorhexidine gluconate-impregnated cloth in the night and morning appeared to reduce the SSI incidence effectively, compared to nosocomial skin preparation alone. In a systematic review and meta-analysis, Cai [41] displayed that chlorhexidine used for preoperative skin preparation could significantly reduce the risk of SSI (RD = –0.02, P < 0.001). An alcohol-based solution of chlorhexidine is also recommended as the first choice by the National Institute for Health and Care Excellence (UK) [42]. However, different opinions exist. Swenson et al. [43] showed that chlorhexidine (8.2%) was associated with a significantly higher postoperative infection rate than povidone iodine and iodine polyacrylate. Carroll et al. [16] revealed that skin preparation using chlorhexidine (0.5%) in alcohol (70%) carried a five-fold increased risk of superficial wound complications, compared to iodine (1%) in alcohol (70%), particularly a 13-fold increased risk in THA. In a cluster randomized controlled trial, Peel et al. [44] also pointed out that iodine-alcohol achieved greater efficacy than chlorhexidine-alcohol. Letzelter et al. [45] demonstrated that the combination of the two disinfectants worked better, particularly in JRS.

Prolonged surgery and one-stage bilateral JRS

Prolonged operations increase the time of wound exposure, likelihood of excessive tissue stripping, blood loss, and duration of anaesthesia. All those factors increase the risk of infection. Teo et al. [46] revealed that protracted operative time was associated with a high rate of SSI in unilateral TKA (90.5 ± 28.2 min vs. 72.2 +± 2 0.3 min; P = 0.03). Sheth et al. [47] reviewed 17,342 primary unilateral TKAs and THAs and found that the incidences of SSI and PJI were significantly higher if the operative time lasted more than 90 min (2.1% and 1.4%, respectively), compared to the operative time between 60 and 90 min (1.1% and 0.7%) and the time less than 60 min (0.9% and 0.7%, respectively; P < 0.01). In a retrospective multicenter study, Liu et al. [8] demonstrated the operative time longer than 107 min was significantly associated with a high rate of wound infection (OR, 2.18, P = 0.001). Theoretically, one-stage bilateral JRS increases the operative time, the amount of bleeding and the probability of blood transfusion. However, several studies failed to show differences between simultaneous and unilateral or staged bilateral TKA and THA in infection rate [48,49,50,51,52].

Glove change

During surgery, surgical gloves may be contaminated, especially in prolonged operations. Glove change reduces the risk of SSI. Kim et al. [53] suggested that surgeons should change their gloves at an interval less than one hour. In addition, they should change their gloves after draping, before handling the implant, and if visible perforations are seen.

Antibiotic prophylaxis

The use of intravenous antibiotics is the most important measure to decrease wound infection. Siddiqi et al. [54] performed a systematic review and meta-analysis based on 31 studies involving 51,627 patients. They demonstrated that the antibiotic prophylaxis was effective in preventing post-JRS infection, but continous use for more than 24 h had no benefit. Christensen et al. [55] retrospectively reviewed 6,080 patients and revealed that single-dose of prophylactic antibiotics was not associated with increased acute PJI and short-term complications, compared to a 24-h antibiotic regimen. Some surgeons reported similar results [56, 57]. Patient-reported allergy to penicillin was most likely to be prescribed with clindamycin (1.1 vs. 80.7%; P < 0.05) or vancomycin (4.0 vs. 12.4%; P < 0.05) rather than cefazolin (94.9 vs. 6.9%; P < 0.05) [58]. However, Zastrow et al. [59] found that antibiotic prophylaxis regimens (vancomycin, clindamycin or combined regimen with cefazolin) were associated with an increased risk of SSI in THA and TKA, compared to cefazolin alone. Cefazolin underdosing was associated with a high rate of post-JRS SSI. Morris et al. [60] suggested that weight-based dosing of cefazolin (body weight ≥ 80 kg, giving 2 g/d; ≥ 120 kg, giving ≥ 3 g/d) should be used in THA and TKA.

Local antibiotic use

Antibiotics alone or in combination with certain substances are placed in the joint cavity to attain antibacterial effect. In addition to systemic antibiotic prophylaxis, local administration of gentamicin-collagen sponges reduces SSI incidence in elderly patients undergoing hemiarthroplasty [61]. Peng et al. [62] conducted a meta-analysis and found that local use of vancomycin powder significantly decreased the SSI rate after primary JRS but did not change the bacterial spectrum involved. Buchalter et al. [63] reported that vancomycin powder combined with diluted povidone-iodine lavage was associated with a decreased incidence of PJI after primary TKA.

Wound management

The need to drain is always a controversial issue. In a systematic review on SSI, Resende et al. [15] did not find a statistically significant difference in SSI rate between the patients with and without drainage. Doman et al. [64] suggested that use of a closed incision negative pressure wound therapy decreased wound complications, compared to closed silver-impregnated dressing (6.9% vs. 16.2%, P = 0.031). They suggested that a negative pressure wound therapy be used in high-risk patients, especially in patients undergoing non-aspirin anticoagulant therapy. In a prospective randomized controlled study, Kuo et al. [65] demonstrated that the incidence of superficial SSI was significantly lower in the Aquacel Ag Surgical dressing group (0.8%, 95% CI: 0.00–2.48) than in the control group (8.3%, 95% CI: 3.32–13.3; P = 0.01). Some surgeons suggested that antibiotic-coated sutures be used to decrease SSI, but offered no strong supporting evidence [66, 67].

Postoperative hematoma

The chemical thromboprophylaxis used in JRS to reduce deep venous thrombosis and pulmonary thrombosis may cause hematoma. Hematoma is a suitable culture medium for bacterial reproduction and growth. De Jong et al. [35] showed that postoperative hematoma was associated with an increased risk of deep infection after hemiarthroplasty. Saleh et al. [68] found that hematoma formation (OR = 11.8; P < 0.05) was a significant predictor of superficial SSI in TKA and THA.

Doctors, hospitals, and others

Preoperative Staphylococcus aureus screening and decolonization are helpful to reduce bacteria colonization, transmission, and surgical site infection. Saleh et al. [69] found methicillin-resistant Staphylococcus aureus undergoing the selective treatment showed confirmed eradication, but a significantly increased risk of SSI remains in THA and TKA. This evidence suggests that preoperative bacterial screening and decolonization should be conducted. Weiser and Moucha [70] found that non-colonization of Staphylococcus aureus screened in the nasal cavity could potentially reduce the incidence of SSI. Zhu et al. [71] revealed that screening and decolonization of nasal Staphylococcus aureus significantly reduced the risks of SSI, PJI and superficial infections, compared to the non-decolonization group. The latest systematic review and meta-analysis showed that non-decolonization was associated with a higher risk of Staphylococcus aureus infection (RR = 2.18 ± 0.41) and other infections (RR = 1.70 ± 0.17) in elective JRS [72].

Doctor’s operation volume and experience

De Jong et al. [35] found that a surgeon’s experience is an independent factor in preventing infection. Surgeons who had performed more JRS had a lower SSI rate. In a prospective cohort study, however, Finkelstein et al. [73] did not find a statistically significant difference between the surgeons who performed high-volume operations and those who did low-volume operations (4.3% vs. 4.9%, P = 0.65).

Socioeconomic factors

Wu et al. [6] reported that patients living in rural areas had a 2.63-fold increased risk of PJI than urban patients. Rural patients are more likely to experience a delayed diagnosis and treatment due to irregular outpatient visits. Ong et al. [74] also found that the patients undergoing public assistance for Medicare premium were associated with an increased risk of PJI (OR: 1.34, P = 0.005). Patients on low-income government insurance (Medicaid) had a higher incidence of SSI after shoulder arthroplasty during the initial inpatient stay [75]. Compared to Medicare, the patients who primarily had Medicaid were most likely to experience a higher (> 49%) risk of SSI 30 days after TKA [76]. Poor living conditions and nutritional levels, pre-existing comorbidities, non-compliance with medical advice, and failure to seek timely care in a lower socioeconomic environment render the patients more vulnerable to an increased risk of infection [77].

Seasonal factors

Kane et al.[78] found that incidences of infection were higher in July (4.5%), August (5.4%), and September (4.3%) than in the intermediate periods between summer and autumn months (3.6%) and winter and spring months (1%). For post-TKA infection, the 30-day readmission rate of June (peak) was 30.5% higher than that of December (trough) [75]. For post-THA infection, the readmission rate of July (peak) was 19% higher than that of January (trough). In a retrospective nationwide study, Yamagami et al. [79] also showed that summer season was associated with higher rates of post-TKA and post-unicompartmental knee arthroplasty SSI and PJI. It may be attributed to a larger skin bacterial population at higher temperatures and humidity [80]. In addition, the “July effect” (new medical student arrival) was associated with lower quality of wound care and a higher incidence of SSI [77].

Prevention of SSI

For invariable factors, such as sex and age, doctors should inform the patients and their family members about the risks. The surgical team should optimize those modifiable factors to decrease the risk of SSI (Table 1).

Table 1 A summary of risk factors associated with post-JRS SSI

Conclusions

Preoperatively, the surgeon should fully evaluate patients’ habits, medical history, and health conditions. Some important measures should be taken: (1) quit tobacco and alcohol or even have a cessation program; (2) optimize perioperative levels of blood glucose of diabetic patients; (3) support the patient’s diet to achieve a normal level of hemoglobin and nutritional status; (4) optimize patient’s comorbidities, such as rheumatoid arthritis, peripheral vascular disease, chronic skin disease, etc. and (5) perform nasal Staphylococcus aureus screening, decolonization, and antibiotic prophylaxis.

Intraoperatively, the surgical team should strictly control the sterility, shorten the operative time, and minimize the trauma as much as possible. Several issues need to be addressed: (1) use Iodine-alcohol for preoperative skin preparation; (2) change gloves after draping, before handling implants or in the presence of perforations; and (3) use a ventilation system with 100-level laminar flow in the operating room.

Postoperatively, the surgeons should strictly keep dressing change aseptic, follow-up patients regularly, and address complications in a timely manner. The patient should be informed to consult surgeons if there are wound redness, swelling, and discomfort in the knee. The patient should be prescribed oral antibiotics to prevent blood-borne infection, if they had dental procedures.

Availability of data and materials

No applicable

Abbreviations

SSI:

Surgical site infection

JRS:

Joint replacement surgery

PJI:

Periprosthetic joint infection

THA:

Total hip arthroplasty

TKA:

Total knee arthroplasty

ASA:

American Society of Anesthesiologists

ciNPWT:

Closed incision negative pressure wound therapy

BMI:

Body Mass Index

References

  1. Gundtoft PH, Pedersen AB, Varnum C, Overgaard S. Increased mortality after prosthetic joint infection in primary THA. Clin Orthop Relat Res. 2017;475(11):2623–31.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Kapadia BH, Berg RA, Daley JA, Fritz J, Bhave A, Mont MA. Periprosthetic joint infection. Lancet. 2016;387(10016):386–94. https://doi.org/10.1016/S0140-6736(14)61798-0.

    Article  PubMed  Google Scholar 

  3. Del Pozo JL, Patel R. Clinical practice. Infection associated with prosthetic joints. N Engl J Med. 2009;361(8):787–94. https://doi.org/10.1056/NEJMcp0905029.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Kurtz SM, Lau E, Watson H, Schmier JK, Parvizi J. Economic burden of periprosthetic joint infection in the United States. J Arthroplasty. 2012;27(8 Suppl):61-5.e1. https://doi.org/10.1016/j.arth.2012.02.022.

    Article  PubMed  Google Scholar 

  5. Ridgeway S, Wilson J, Charlet A, Kafatos G, Pearson A, Coello R. Infection of the surgical site after arthroplasty of the hip. J Bone Joint Surg Br. 2005;87(6):844–50. https://doi.org/10.1302/0301-620X.87B6.15121.

    CAS  Article  PubMed  Google Scholar 

  6. Wu C, Qu X, Liu F, Li H, Mao Y, Zhu Z. Risk factors for periprosthetic joint infection after total hip arthroplasty and total knee arthroplasty in Chinese patients. PLoS ONE. 2014;9(4):e95300. https://doi.org/10.1371/journal.pone.0095300.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Cordero-Ampuero J, de Dios M. What are the risk factors for infection in hemiarthroplasties and total hip arthroplasties? Clin Orthop Relat Res. 2010;468(12):3268–77. https://doi.org/10.1007/s11999-010-1411-8.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Liu X, Dong Z, Li J, Feng Y, Cao G, Song X, Yang J. Factors affecting the incidence of surgical site infection after geriatric hip fracture surgery: a retrospective multicenter study. J Orthop Surg Res. 2019;14(1):382. https://doi.org/10.1186/s13018-019-1449-6.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  9. Muilwijk J, Walenkamp GH, Voss A, Wille JC, van den Hof S. Random effect modelling of patient-related risk factors in orthopaedic procedures: results from the Dutch nosocomial infection surveillance network ‘PREZIES.’ J Hosp Infect. 2006;62(3):319–26. https://doi.org/10.1016/j.jhin.2005.08.006.

    CAS  Article  PubMed  Google Scholar 

  10. Baier C, Adelmund S, Schwab F, Lassahn C, Chaberny IF, Gossé F, Vonberg RP, Ebadi E. Incidence and risk factors of surgical site infection after total knee arthroplasty: Results of a retrospective cohort study. Am J Infect Control. 2019;47(10):1270–2. https://doi.org/10.1016/j.ajic.2019.04.010.

    Article  PubMed  Google Scholar 

  11. Willis-Owen CA, Konyves A, Martin DK. Factors affecting the incidence of infection in hip and knee replacement: an analysis of 5277 cases. J Bone Joint Surg Br. 2010;92(8):1128–33. https://doi.org/10.1302/0301-620X.92B8.24333.

    CAS  Article  PubMed  Google Scholar 

  12. Poultsides LA, Ma Y, Della Valle AG, Chiu YL, Sculco TP, Memtsoudis SG. In-hospital surgical site infections after primary hip and knee arthroplasty–incidence and risk factors. J Arthroplasty. 2013;28(3):385–9. https://doi.org/10.1016/j.arth.2012.06.027.

    Article  PubMed  Google Scholar 

  13. Dale H, Fenstad AM, Hallan G, Havelin LI, Furnes O, Overgaard S, Pedersen AB, Kärrholm J, Garellick G, Pulkkinen P, Eskelinen A, Mäkelä K, Engesæter LB. Increasing risk of prosthetic joint infection after total hip arthroplasty. Acta Orthop. 2012;83(5):449–58. https://doi.org/10.3109/17453674.2012.733918.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Namba RS, Inacio MC, Paxton EW. Risk factors associated with surgical site infection in 30,491 primary total hip replacements. J Bone Joint Surg Br. 2012;94(10):1330–8. https://doi.org/10.1302/0301-620X.94B10.29184.

    CAS  Article  PubMed  Google Scholar 

  15. Resende VAC, Neto AC, Nunes C, Andrade R, Espregueira-Mendes J, Lopes S. Higher age, female gender, osteoarthritis and blood transfusion protect against periprosthetic joint infection in total hip or knee arthroplasties: a systematic review and meta-analysis. Knee Surg Sports Traumatol Arthrosc. 2021;29(1):8–43. https://doi.org/10.1007/s00167-018-5231-9.

    Article  PubMed  Google Scholar 

  16. Carroll K, Dowsey M, Choong P, Peel T. Risk factors for superficial wound complications in hip and knee arthroplasty. Clin Microbiol Infect. 2014;20(2):130–5. https://doi.org/10.1111/1469-0691.12209.

    CAS  Article  PubMed  Google Scholar 

  17. Maoz G, Phillips M, Bosco J, Slover J, Stachel A, Inneh I, Iorio R. The Otto Aufranc Award: Modifiable versus nonmodifiable risk factors for infection after hip arthroplasty. Clin Orthop Relat Res. 2015;473(2):453–9. https://doi.org/10.1007/s11999-014-3780-x.

    Article  PubMed  Google Scholar 

  18. Bozic KJ, Lau E, Kurtz S, Ong K, Rubash H, Vail TP, Berry DJ. Patient-related risk factors for periprosthetic joint infection and postoperative mortality following total hip arthroplasty in Medicare patients. J Bone Joint Surg Am. 2012;94(9):794–800. https://doi.org/10.2106/JBJS.K.00072.

    Article  PubMed  Google Scholar 

  19. Liang Z, Rong K, Gu W, Yu X, Fang R, Deng Y, Lu L. Surgical site infection following elective orthopaedic surgeries in geriatric patients: Incidence and associated risk factors. Int Wound J. 2019;16(3):773–80. https://doi.org/10.1111/iwj.13096.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Falagas ME, Kompoti M. Obesity and infection. Lancet Infect Dis. 2006;6(7):438–46. https://doi.org/10.1016/S1473-3099(06)70523-0.

    Article  PubMed  Google Scholar 

  21. Pruzansky JS, Bronson MJ, Grelsamer RP, Strauss E, Moucha CS. Prevalence of modifiable surgical site infection risk factors in hip and knee joint arthroplasty patients at an urban academic hospital. J Arthroplasty. 2014;29(2):272–6. https://doi.org/10.1016/j.arth.2013.06.019.

    Article  PubMed  Google Scholar 

  22. Rasouli MR, Restrepo C, Maltenfort MG, Purtill JJ, Parvizi J. Risk factors for surgical site infection following total joint arthroplasty. J Bone Joint Surg Am. 2014;96(18): e158. https://doi.org/10.2106/JBJS.M.01363.

    Article  PubMed  Google Scholar 

  23. Song KH, Kim ES, Kim YK, Jin HY, Jeong SY, Kwak YG, Cho YK, Sung J, Lee YS, Oh HB, Kim TK, Koo KH, Kim EC, Kim JM, Choi TY, Kim HY, Choi HJ, Kim HB. Differences in the risk factors for surgical site infection between total hip arthroplasty and total knee arthroplasty in the Korean Nosocomial Infections Surveillance System (KONIS). Infect Control Hosp Epidemiol. 2012;33(11):1086–93. https://doi.org/10.1086/668020.

    Article  PubMed  Google Scholar 

  24. Iorio R, Williams KM, Marcantonio AJ, Specht LM, Tilzey JF, Healy WL. Diabetes mellitus, hemoglobin A1C, and the incidence of total joint arthroplasty infection. J Arthroplasty. 2012;27(5):726-9.e1. https://doi.org/10.1016/j.arth.2011.09.013.

    Article  PubMed  Google Scholar 

  25. Shohat N, Muhsen K, Gilat R, Rondon AJ, Chen AF, Parvizi J. Inadequate Glycemic Control Is Associated With Increased Surgical Site Infection in Total Joint Arthroplasty: A Systematic Review and Meta-Analysis. J Arthroplasty. 2018;33(7):2312-2321.e3. https://doi.org/10.1016/j.arth.2018.02.020.

    Article  PubMed  Google Scholar 

  26. Kaiafa G, Veneti S, Polychronopoulos G, Pilalas D, Daios S, Kanellos I, Didangelos T, Pagoni S, Savopoulos C. Is HbA1c an ideal biomarker of well-controlled diabetes? Postgrad Med J. 2021;97(1148):380–3. https://doi.org/10.1136/postgradmedj-2020-138756.

    Article  PubMed  Google Scholar 

  27. Momohara S, Kawakami K, Iwamoto T, Yano K, Sakuma Y, Hiroshima R, Imamura H, Masuda I, Tokita A, Ikari K. Prosthetic joint infection after total hip or knee arthroplasty in rheumatoid arthritis patients treated with nonbiologic and biologic disease-modifying antirheumatic drugs. Mod Rheumatol. 2011;21(5):469–75. https://doi.org/10.1007/s10165-011-0423-x.

    Article  PubMed  Google Scholar 

  28. Everhart JS, Bishop JY, Barlow JD. Medical comorbidities and perioperative allogeneic red blood cell transfusion are risk factors for surgical site infection after shoulder arthroplasty. J Shoulder Elbow Surg. 2017;26(11):1922–30. https://doi.org/10.1016/j.jse.2017.04.006.

    Article  PubMed  Google Scholar 

  29. Sousa R, Muñoz-Mahamud E, Quayle J, Dias da Costa L, Casals C, Scott P, Leite P, Vilanova P, Garcia S, Ramos MH, Dias J, Soriano A, Guyot A. Is asymptomatic bacteriuria a risk factor for prosthetic joint infection? Clin Infect Dis. 2014;59(1):41–7. https://doi.org/10.1093/cid/ciu235.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Gómez-Ochoa SA, Espín-Chico BB, García-Rueda NA, Vega-Vera A, Osma-Rueda JL. Risk of Surgical Site Infection in Patients with Asymptomatic Bacteriuria or Abnormal Urinalysis before Joint Arthroplasty: Systematic Review and Meta-Analysis. Surg Infect (Larchmt). 2019;20(3):159–66. https://doi.org/10.1089/sur.2018.201.

    Article  Google Scholar 

  31. Pulido L, Ghanem E, Joshi A, Purtill JJ, Parvizi J. Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res. 2008;466(7):1710–5. https://doi.org/10.1007/s11999-008-0209-4.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Schmitt DR, Schneider AM, Brown NM. Impact of Perioperative Urinary Tract Infection on Surgical Site Infection in Patients Undergoing Primary Hip and Knee Arthroplasty. J Arthroplasty. 2020;35(10):2977–82. https://doi.org/10.1016/j.arth.2020.05.025.

    Article  PubMed  Google Scholar 

  33. Marusic V, Markovic-Denic L, Djuric O, Cirkovic A, Nikolic V, Dubljanin-Raspopovic E, Kadija M. Incidence and Risk Factors of 30-Day Surgical Site Infection after Primary Total Joint Arthroplasty in a Middle-Income Country: A Single-Center Experience. Int J Environ Res Public Health. 2021;18(3):863. https://doi.org/10.3390/ijerph18030863.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Park IH, Lee SC, Park IS, Nam CH, Ahn HS, Park HY, Gondalia VH, Jung KA. Asymptomatic peripheral vascular disease in total knee arthroplasty: preoperative prevalence and risk factors. J Orthop Traumatol. 2015;16(1):23–6. https://doi.org/10.1007/s10195-014-0305-z.

    Article  PubMed  Google Scholar 

  35. de Jong L, Klem TMAL, Kuijper TM, Roukema GR. Factors affecting the rate of surgical site infection in patients after hemiarthroplasty of the hip following a fracture of the neck of the femur. Bone Joint J. 2017;99-B(8):1088–94. https://doi.org/10.1302/0301-620X.99B8.BJJ-2016-1119.R1.

    Article  PubMed  Google Scholar 

  36. Pugely AJ, Martin CT, Gao Y, Schweizer ML, Callaghan JJ. The incidence of and Risk Factors for 30-Day Surgical Site Infections Following Primary and Revision Total Joint Arthroplasty. J Arthroplasty. 2015;30(9 Suppl):47–50. https://doi.org/10.1016/j.arth.2015.01.063.

    Article  PubMed  Google Scholar 

  37. Bedard NA, DeMik DE, Owens JM, Glass NA, DeBerg J, Callaghan JJ. Tobacco Use and Risk of Wound Complications and Periprosthetic Joint Infection: A Systematic Review and Meta-Analysis of Primary Total Joint Arthroplasty Procedures. J Arthroplasty. 2019;34(2):385-396.e4. https://doi.org/10.1016/j.arth.2018.09.089.

    Article  PubMed  Google Scholar 

  38. Paryavi E, Stall A, Gupta R, Scharfstein DO, Castillo RC, Zadnik M, Hui E, O’Toole RV. Predictive model for surgical site infection risk after surgery for high-energy lower-extremity fractures: development of the risk of infection in orthopedic trauma surgery score. J Trauma Acute Care Surg. 2013;74(6):1521–7. https://doi.org/10.1097/TA.0b013e318292158d.

    Article  PubMed  Google Scholar 

  39. Yang G, Zhu Y, Zhang Y. Prognostic risk factors of surgical site infection after primary joint arthroplasty: A retrospective cohort study. Medicine (Baltimore). 2020;99(8):e19283. https://doi.org/10.1097/MD.0000000000019283.

    Article  Google Scholar 

  40. Zywiel MG, Daley JA, Delanois RE, Naziri Q, Johnson AJ, Mont MA. Advance preoperative chlorhexidine reduces the incidence of surgical site infections in knee arthroplasty. Int Orthop. 2011;35(7):1001–6. https://doi.org/10.1007/s00264-010-1078-5.

    Article  PubMed  Google Scholar 

  41. Cai Y, Xu K, Hou W, Yang Z, Xu P. Preoperative chlorhexidine reduces the incidence of surgical site infections in total knee and hip arthroplasty: A systematic review and meta-analysis. Int J Surg. 2017;39:221–8. https://doi.org/10.1016/j.ijsu.2017.02.004.

    Article  PubMed  Google Scholar 

  42. exceptional surveillance of surgical site infections. prevention and treatment (NICE guideline NG125) [Internet]. London: National Institute for Health and Care Excellence (UK); 2019.

    Google Scholar 

  43. Swenson BR, Hedrick TL, Metzger R, Bonatti H, Pruett TL, Sawyer RG. Effects of preoperative skin preparation on postoperative wound infection rates: a prospective study of 3 skin preparation protocols. Infect Control Hosp Epidemiol. 2009;30(10):964–71. https://doi.org/10.1086/605926.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Peel TN, Dowsey MM, Buising KL, Cheng AC, Choong PFM. Chlorhexidine-alcohol versus iodine-alcohol for surgical site skin preparation in an elective arthroplasty (ACAISA) study: a cluster randomized controlled trial. Clin Microbiol Infect. 2019;25(10):1239–45. https://doi.org/10.1016/j.cmi.2019.06.016.

    CAS  Article  PubMed  Google Scholar 

  45. Letzelter J, Hill JB, Hacquebord J. An Overview of Skin Antiseptics Used in Orthopaedic Surgery Procedures. J Am Acad Orthop Surg. 2019;27(16):599–606. https://doi.org/10.5435/JAAOS-D-18-00105.

    Article  PubMed  Google Scholar 

  46. Teo BJX, Yeo W, Chong HC, Tan AHC. Surgical site infection after primary total knee arthroplasty is associated with a longer duration of surgery. J Orthop Surg (Hong Kong). 2018;26(2):2309499018785647. https://doi.org/10.1177/2309499018785647.

    Article  Google Scholar 

  47. Wang Q, Goswami K, Shohat N, Aalirezaie A, Manrique J, Parvizi J. Longer Operative Time Results in a Higher Rate of Subsequent Periprosthetic Joint Infection in Patients Undergoing Primary Joint Arthroplasty. J Arthroplasty. 2019;34(5):947–53. https://doi.org/10.1016/j.arth.2019.01.027.

    Article  PubMed  Google Scholar 

  48. Hart A, Antoniou J, Brin YS, Huk OL, Zukor DJ, Bergeron SG. Simultaneous Bilateral Versus Unilateral Total Knee Arthroplasty: A Comparison of 30-Day Readmission Rates and Major Complications. J Arthroplasty. 2016;31(1):31–5. https://doi.org/10.1016/j.arth.2015.07.031.

    Article  PubMed  Google Scholar 

  49. Sheth DS, Cafri G, Paxton EW, Namba RS. Bilateral Simultaneous vs Staged Total Knee Arthroplasty: A Comparison of Complications and Mortality. J Arthroplasty. 2016;31(9 Suppl):212–6. https://doi.org/10.1016/j.arth.2016.03.018.

    Article  PubMed  Google Scholar 

  50. Bini SA, Khatod M, Inacio MC, Paxton EW. Same-day versus staged bilateral total knee arthroplasty poses no increase in complications in 6672 primary procedures. J Arthroplasty. 2014;29(4):694–7. https://doi.org/10.1016/j.arth.2012.09.009.

    Article  PubMed  Google Scholar 

  51. Parvizi J, Pour AE, Peak EL, Sharkey PF, Hozack WJ, Rothman RH. One-stage bilateral total hip arthroplasty compared with unilateral total hip arthroplasty: a prospective study. J Arthroplasty. 2006;21(6 Suppl 2):26–31. https://doi.org/10.1016/j.arth.2006.04.013.

    Article  PubMed  Google Scholar 

  52. Balato G, Barbaric K, Bićanić G, Bini S, Chen J, Crnogaca K, Kenanidis E, Giori N, Goel R, Hirschmann M, Marcacci M, AmatMateu C, Nam D, Shao H, Shen B, Tarabichi M, Tarabichi S, Tsiridis E, Tzavellas AN. Hip and knee section, prevention, surgical technique: proceedings of international consensus on orthopedic infections. J Arthroplasty. 2019;34(2S):S301–7. https://doi.org/10.1016/j.arth.2018.09.015.

    Article  PubMed  Google Scholar 

  53. Kim K, Zhu M, Munro JT, Young SW. Glove change to reduce the risk of surgical site infection or prosthetic joint infection in arthroplasty surgeries: a systematic review. ANZ J Surg. 2019;89(9):1009–15. https://doi.org/10.1111/ans.14936.

    Article  PubMed  Google Scholar 

  54. Siddiqi A, Forte SA, Docter S, Bryant D, Sheth NP, Chen AF. Perioperative Antibiotic Prophylaxis in Total Joint Arthroplasty: A Systematic Review and Meta-Analysis. J Bone Joint Surg Am. 2019;101(9):828–42. https://doi.org/10.2106/JBJS.18.00990.

    Article  PubMed  Google Scholar 

  55. Christensen DD, Moschetti WE, Brown MG, Lucas AP, Jevsevar DS, Fillingham YA. Dartmouth Hitchcock Medical Center. Perioperative Antibiotic Prophylaxis: Single and 24-Hour Antibiotic Dosages are Equally Effective at Preventing Periprosthetic Joint Infection in Total Joint Arthroplasty. J Arthroplasty. 2021;36(7S):S308–13. https://doi.org/10.1016/j.arth.2021.02.037.

    Article  PubMed  Google Scholar 

  56. Tan TL, Shohat N, Rondon AJ, Foltz C, Goswami K, Ryan SP, Seyler TM, Parvizi J. Perioperative Antibiotic Prophylaxis in Total Joint Arthroplasty: A Single Dose Is as Effective as Multiple Doses. J Bone Joint Surg Am. 2019;101(5):429–37. https://doi.org/10.2106/JBJS.18.00336.

    Article  PubMed  Google Scholar 

  57. Wyles CC, Vargas-Hernandez JS, Carlson SW, Carlson BC, Sierra RJ. Single-Dose Perioperative Antibiotics Do Not Increase the Risk of Surgical Site Infection in Unicompartmental Knee Arthroplasty. J Arthroplasty. 2019;34(7S):S327–30. https://doi.org/10.1016/j.arth.2019.02.041.

    Article  PubMed  Google Scholar 

  58. Stone AH, Kelmer G, MacDonald JH, Clance MR, King PJ. The Impact of Patient-Reported Penicillin Allergy on Risk for Surgical Site Infection in Total Joint Arthroplasty. J Am Acad Orthop Surg. 2019;27(22):854–60. https://doi.org/10.5435/JAAOS-D-18-00709.

    Article  PubMed  Google Scholar 

  59. Zastrow RK, Huang HH, Galatz LM, Saunders-Hao P, Poeran J, Moucha CS. Characteristics of Antibiotic Prophylaxis and Risk of Surgical Site Infections in Primary Total Hip and Knee Arthroplasty. J Arthroplasty. 2020;35(9):2581–9. https://doi.org/10.1016/j.arth.2020.04.025.

    Article  PubMed  Google Scholar 

  60. Morris AJ, Roberts SA, Grae N, Frampton CM. Surgical site infection rate is higher following hip and knee arthroplasty when cefazolin is underdosed. Am J Health Syst Pharm. 2020;77(6):434–40. https://doi.org/10.1093/ajhp/zxz344.

    Article  PubMed  Google Scholar 

  61. Westberg M, Frihagen F, Brun OC, Figved W, Grøgaard B, Valland H, Wangen H, Snorrason F. Effectiveness of gentamicin-containing collagen sponges for prevention of surgical site infection after hip arthroplasty: a multicenter randomized trial. Clin Infect Dis. 2015;60(12):1752–9. https://doi.org/10.1093/cid/civ162.

    Article  PubMed  Google Scholar 

  62. Peng Z, Lin X, Kuang X, Teng Z, Lu S. The application of topical vancomycin powder for the prevention of surgical site infections in primary total hip and knee arthroplasty: A meta-analysis. Orthop Traumatol Surg Res. 2021;107(4):102741. https://doi.org/10.1016/j.otsr.2020.09.006.

    Article  PubMed  Google Scholar 

  63. Buchalter DB, Kirby DJ, Teo GM, Iorio R, Aggarwal VK, Long WJ. Topical Vancomycin Powder and Dilute Povidone-Iodine Lavage Reduce the Rate of Early Periprosthetic Joint Infection After Primary Total Knee Arthroplasty. J Arthroplasty. 2021;36(1):286-290.e1. https://doi.org/10.1016/j.arth.2020.07.064.

    Article  PubMed  Google Scholar 

  64. Doman DM, Young AM, Buller LT, Deckard ER, Meneghini RM. Comparison of Surgical Site Complications With Negative Pressure Wound Therapy vs Silver Impregnated Dressing in High-Risk Total Knee Arthroplasty Patients: A Matched Cohort Study. J Arthroplasty. 2021:S0883–5403(21)00512-X. doi: https://doi.org/10.1016/j.arth.2021.05.030.

  65. Kuo FC, Chen B, Lee MS, Yen SH, Wang JW. AQUACEL® Ag Surgical Dressing Reduces Surgical Site Infection and Improves Patient Satisfaction in Minimally Invasive Total Knee Arthroplasty: A Prospective, Randomized. Controlled Study Biomed Res Int. 2017;2017:1262108. https://doi.org/10.1155/2017/1262108.

    Article  PubMed  Google Scholar 

  66. Sprowson AP, Jensen C, Parsons N, Partington P, Emmerson K, Carluke I, Asaad S, Pratt R, Muller S, Ahmed I, Reed MR. The effect of triclosan-coated sutures on the rate of surgical site infection after hip and knee arthroplasty: a double-blind randomized controlled trial of 2546 patients. Bone Joint J. 2018;100-B(3):296–302. https://doi.org/10.1302/0301-620X.100B3.BJJ-2017-0247.R1.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  67. Sprowson AP, Jensen C, Ahmed I, Parsons N, Partington P, Emmerson K, Carluke I, Asaad S, Pratt R, Muller S, Reed MR. Infographic: Triclosan-coated sutures and surgical site infections after hip and knee arthroplasty. Bone Joint J. 2018;100-B(3):294–5. https://doi.org/10.1302/0301-620X.100B3.BJJ-2018-0099.

    CAS  Article  PubMed  Google Scholar 

  68. Saleh K, Olson M, Resig S, Bershadsky B, Kuskowski M, Gioe T, Robinson H, Schmidt R, McElfresh E. Predictors of wound infection in hip and knee joint replacement: results from a 20 year surveillance program. J Orthop Res. 2002;20(3):506–15. https://doi.org/10.1016/S0736-0266(01)00153-X.

    Article  PubMed  Google Scholar 

  69. Tandon T, Tadros BJ, Akehurst H, Avasthi A, Hill R, Rao M. Risk of Surgical Site Infection in Elective Hip and Knee Replacements After Confirmed Eradication of MRSA in Chronic Carriers. J Arthroplasty. 2017;32(12):3711–7. https://doi.org/10.1016/j.arth.2017.06.036.

    Article  PubMed  Google Scholar 

  70. Weiser MC, Moucha CS. The Current State of Screening and Decolonization for the Prevention of Staphylococcus aureus Surgical Site Infection After Total Hip and Knee Arthroplasty. J Bone Joint Surg Am. 2015;97(17):1449–58. https://doi.org/10.2106/JBJS.N.01114.

    Article  PubMed  Google Scholar 

  71. Zhu X, Sun X, Zeng Y, Feng W, Li J, Zeng J, Zeng Y. Can nasal Staphylococcus aureus screening and decolonization prior to elective total joint arthroplasty reduce surgical site and prosthesis-related infections? A systematic review and meta-analysis. J Orthop Surg Res. 2020;15(1):60. https://doi.org/10.1186/s13018-020-01601-0.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Ribau AI, Collins JE, Chen AF, Sousa RJ. Is Preoperative Staphylococcus aureus Screening and Decolonization Effective at Reducing Surgical Site Infection in Patients Undergoing Orthopedic Surgery? A Systematic Review and Meta-Analysis With a Special Focus on Elective Total Joint Arthroplasty. J Arthroplasty. 2021;36(2):752-766.e6. https://doi.org/10.1016/j.arth.2020.08.014.

    Article  PubMed  Google Scholar 

  73. Finkelstein R, Eluk O, Mashiach T, Levin D, Peskin B, Nierenberg G, Karkabi S, Soudri M. Reducing surgical site infections following total hip and knee arthroplasty: an Israeli experience. Musculoskelet Surg. 2017;101(3):219–25. https://doi.org/10.1007/s12306-017-0471-2 Epub 2017 Mar 21.

    CAS  Article  PubMed  Google Scholar 

  74. Ong KL, Kurtz SM, Lau E, Bozic KJ, Berry DJ, Parvizi J. Prosthetic joint infection risk after total hip arthroplasty in the Medicare population. J Arthroplasty. 2009;24(6 Suppl):105–9. https://doi.org/10.1016/j.arth.2009.04.027.

    Article  PubMed  Google Scholar 

  75. Smucny M, Menendez ME, Ring D, Feeley BT, Zhang AL. Inpatient surgical site infection after shoulder arthroplasty. J Shoulder Elbow Surg. 2015;24(5):747–53. https://doi.org/10.1016/j.jse.2014.12.024.

    Article  PubMed  Google Scholar 

  76. Anthony CA, Peterson RA, Sewell DK, Polgreen LA, Simmering JE, Callaghan JJ, Polgreen PM. The Seasonal Variability of Surgical Site Infections in Knee and Hip Arthroplasty. J Arthroplasty. 2018;33(2):510-514.e1. https://doi.org/10.1016/j.arth.2017.10.043.

    Article  PubMed  Google Scholar 

  77. Triantafyllopoulos G, Stundner O, Memtsoudis S, Poultsides LA. Patient, Surgery, and Hospital Related Risk Factors for Surgical Site Infections following Total Hip Arthroplasty. ScientificWorldJournal. 2015;2015:979560. https://doi.org/10.1155/2015/979560.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Kane P, Chen C, Post Z, Radcliff K, Orozco F, Ong A. Seasonality of infection rates after total joint arthroplasty. Orthopedics. 2014;37(2):e182–6. https://doi.org/10.3928/01477447-20140124-23.

    Article  PubMed  Google Scholar 

  79. Yamagami R, Inui H, Jo T, Kawata M, Taketomi S, Kono K, Kawaguchi K, Sameshima S, Kage T, Matsui H, Fushimi K, Yasunaga H, Tanaka S. Unicompartmental knee arthroplasty is associated with lower proportions of surgical site infection compared with total knee arthroplasty: A retrospective nationwide database study. Knee. 2021;28:124–30. https://doi.org/10.1016/j.knee.2020.11.017.

    Article  PubMed  Google Scholar 

  80. McBride ME, Duncan WC, Knox JM. The environment and the microbial ecology of human skin. Appl Environ Microbiol. 1977;33(3):603–8. https://doi.org/10.1128/aem.33.3.603-608.1977.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Not applicable

Funding

Not applicable

Author information

Authors and Affiliations

Authors

Contributions

T Li, PK Chan, WC Fung, H Fu and HN Zhang searched the literature and drafted the manuscript. PK Chan and KY Chiu developed the idea for the study and revised the manuscript. The authors read and authorized the final manuscript for publication.

Corresponding author

Correspondence to Ping Keung Chan.

Ethics declarations

Ethics approval and consent to participate:

Not applicable

Consent for publication

Not applicable

Competing interests

The authors declare that they have no competing interests and they were not involved in the journal’s review of or decisions related to, this manuscript.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Li, T., Zhang, H., Chan, P.K. et al. Risk factors associated with surgical site infections following joint replacement surgery: a narrative review. Arthroplasty 4, 11 (2022). https://doi.org/10.1186/s42836-022-00113-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s42836-022-00113-y

Keywords

  • Surgical site infection
  • Risk factor
  • Joint replacement